The Cell & Gene by Oxford Global #GeneTherapy 2024 Congress started today, and what a day it has been full of information and connections. Looking forward to closing out the week strong here in #London!
Ascend Advanced Therapies’ Post
More Relevant Posts
-
PhD in Molecular Biology. Life Sciences Scientific Advisor for South Europe (Italy, Spain and Portugal)
Gene editing technologies hold immense potential, but the complexities and design hurdles can be challenging. In this Labroots webinar, Dr. Fuqiang Chen will dive deep into the critical factors that impact success in gene editing. Cleavage position, nuclease selection, donor design and prep, and cell culture conditions play pivotal roles in editing efficiency. Register now to learn tips and tricks on how to optimize these factors for more desirable outcomes. #alwayscurious
To view or add a comment, sign in
-
Collagen plays an important role in giving structure to and strengthening the skin. Mutations in the COL7A1 gene cause both dominant and recessive forms of dystrophic epidermolysis bullosa. This gene provides instructions for making a protein that forms subunits of type VII collagen. Without it, skin is fragile and blisters easily. Learn more about #DEB: https://krys.bio/ya6 #DEB
To view or add a comment, sign in
-
Ever wondered how identical nerve cells diverge into specialized functions? Join our upcoming webinar with Prof. Longzhi Tan to hear about his groundbreaking research that unveils the mysteries behind gene specialization through 3D genome structure. Sony Biotechnology Inc. #genome #nervecells #3dgenomestructure #genetranscription #DNAsequencing
Register here
To view or add a comment, sign in
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
To view or add a comment, sign in
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
To view or add a comment, sign in
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
To view or add a comment, sign in
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
To view or add a comment, sign in
-
Did you know? Our study is recruiting patients w/ #ATP1A3 gene variants: https://buff.ly/3EN20Wz We aim to better identify characteristics associated w/ #RDP, #AHC & #CAPOS. We also aim to explore whether variants in the ATP1A3 gene are linked w/ dystonias & #ParkinsonsDisease.
To view or add a comment, sign in
-
-
"Development of Mitochondria-Inspired Lipopolyplexes for Gene Delivery" This short oral was presented during #TargetingMitochondria 2023 by: Ioannis Tsichlis, National & Kapodistrian University of Athens, Greece #WorldMitochondriaSociety #TargetingMitochondria2023 #mitochondria
To view or add a comment, sign in
-
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
To view or add a comment, sign in